ZANUSSI et al., 1996 - Google Patents
The effects of antineoplastic chemotherapy on HIV diseaseZANUSSI et al., 1996
- Document ID
- 11273179126440650064
- Author
- ZANUSSI S
- SIMONELLI C
- D'ANDREA M
- Comar M
- BIDOLI E
- Giacca M
- TIRELLI U
- VACCHER E
- DE PAOLI P
- Publication year
- Publication venue
- AIDS research and human retroviruses
External Links
Snippet
Six patients with human immunodeficiency virus (HIV)-associated non-Hodgkin lymphoma receiving chemotherapy (CT) with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) plus granulocyte colony-stimulating factor were sequentially monitored …
- 238000002512 chemotherapy 0 title abstract description 55
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fan et al. | Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. | |
| Spina et al. | Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. | |
| Soumelis et al. | Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients | |
| Orendi et al. | Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection | |
| Lewis et al. | Anergy and apoptosis in CD8+ T cells from HIV-infected persons. | |
| Palmer et al. | Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function | |
| Duvall et al. | Polyfunctional T cell responses are a hallmark of HIV‐2 infection | |
| Giorgi et al. | Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage | |
| Ennen et al. | CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. | |
| Imashuku et al. | Haemophagocytic lymphohistiocytosis, interferon‐gamma‐naemia and Epstein‐Barr virus involvement | |
| Kaur et al. | Differential dynamics of CD4+ and CD8+ T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection | |
| Bouscarat et al. | Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy | |
| ZANUSSI et al. | The effects of antineoplastic chemotherapy on HIV disease | |
| Hofmann et al. | Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change | |
| Willerford et al. | Simian immunodeficiency virus is restricted to a subset of blood CD4+ lymphocytes that includes memory cells. | |
| Garaci et al. | Combination treatment with zidovudine, thymosin α 1 and interferon-α in human immunodeficiency virus infectionand interferon-α in human immunodeficiency virus infection | |
| Nkengasong et al. | Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast | |
| Wong et al. | Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons | |
| JPH04506961A (en) | antiviral composition | |
| Vitek et al. | Evidence for sexual and mother-to-child transmission of human T lymphotropic virus type II among Guaymi Indians, Panama | |
| Johnson et al. | Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis | |
| SASAKI et al. | Mycoplasmas stimulate replication of human immunodeficiency virus type 1 through selective activation of CD4+ T lymphocytes | |
| Zaunders et al. | Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+ CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes | |
| Kashanchi et al. | Rapid and sensitive detection of cell‐associated HIV‐1 in latently infected cell lines and in patient cells using sodium‐n‐butyrate induction and RT‐PCR | |
| US5888726A (en) | Pertussis toxin induced lymphocytosis |